SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

NATCO PHARMA

BSE: 524816 29 Jul 2025
Healthcare
₹ 1010.9
Natco Pharma Ltd. specializes in Pharmaceuticals within the Healthcare sector.

NATCO PHARMA - Share Price & Details

Market Cap
₹17,135
High /Low
1,639 / 660.0
Stock P/E
9.1
Book Value
₹425.0
Dividend Yield
1.02
ROCE
32.8
ROE
₹28.0
Face Value
2.0
PEG Ratio
0.07
EVEBITDA
₹5.97
Debt
279
CMP / FCF
18.2
Debt to equity
₹0.04
NP Ann
1,883
High price all time
1,639
Piotroski score
₹8.0
Graham Number
1,003
No. Eq. Shares
17.9
Net CF
₹71.6
Net profit
1,883
Price to book value
2.27
Interest Coverage
₹96.9
Low price all time
7.6
Industry PE
33.4
Reserves
₹7,571
Free Cash Flow
₹1,300

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.4691.0
Triochem Products Ltd.,3.25-4.52NA-18.440
NATCO PHARMA LTD.12,195.004,281.0011,574.0023.9017,1359.1
CAPLIN POINT LABORATORIES LTD.2,148.60865.001,736.1011.351568729.2
Rainbow Children's Medicare Li3540.33517.23347.485.091552760.3

Peer Comparison Chart


About NATCO PHARMA

Natco Pharma Ltd., with Security Code 524816, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Can NATCO Pharma Limited (NATCOPHARM) Maintain Its Valuation - Tremendous portfolio expansion

(26 Jul 2025)
Can NATCO Pharma Limited (NATCOPHARM) Maintain Its Valuation ✌️【Stock Analysis】✌️ Boost your portfolio using expert-picked stocks and...
Read more →

NATCO Pharma Limited (524816) Stock Rallies - Superior capital gains

(25 Jul 2025)
NATCO Pharma Limited (524816) Stock Rallies ✌️【Market Discussions】✌️ With a focus on accuracy and timing, we've built a system that helps...
Read more →

NATCO Pharma API unit in Mekaguda receives EIR from USFDA

(25 Jul 2025)
NATCO Pharma Limited has informed that the U.S. Food and Drug Administration (FDA) had conducted an inspection at the Active Pharmaceutical...
Read more →

Bullish Pattern Emerging on NATCO Pharma Limited (NATCOPHARM) - Exceptional financial outcomes

(24 Jul 2025)
Bullish Pattern Emerging on NATCO Pharma Limited (NATCOPHARM) ✌️【Investment News】✌️ Take advantage of our comprehensive market coverage,...
Read more →

Natco to buy $226 mn stake in South African drugmaker Adcock Ingram

(24 Jul 2025)
Indian pharmaceutical company Natco Pharma Ltd has decided to acquire a 35.75% stake in South Africa's Adcock Ingram ...
Read more →

Natco Pharma Mekaguda API unit gets USFDA EIR

(24 Jul 2025)
Hyderabad: NATCO Pharma Limited has announced that the U.S. Food and Drug Administration (USFDA) has issued an Establishment Inspection...
Read more →

Company Updates